Q4 FY2025 · Earnings release
March 9, 2026 · 11 pages
Read ARS Pharmaceuticals, Inc.'s results firsthand
Preview the first 2 pages of this earnings release
Create a free account to start reading
Full documents are included with Professional
ARS Pharmaceuticals, Inc.
NNASDAQ:SPRY2.79
USD
+0.14
(+5.28%)
